EUGENIA STORMS: Open Payments
NPI 1912543463 · SMITHFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 34 payments from 9 companies in 2025. Trend: 2023 $36 · 2024 $0 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $113 |
| Janssen Pharmaceuticals, Inc | 3 | $96 |
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
| Alkermes, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Braeburn Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, COBENFY, VIVITROL, TRINTELLIX, ARISTADA, UZEDY.
Industry payments across VA — which companies pay providers there.
